Frontotemporal Disorders

CervoMed Secures $10 Million to Advance Brain Disease Pipeline

BOSTON, June 18, 2026 CervoMed Inc., a clinical-stage biotechnology company focused on developing therapies for age-related neurological disorders, has...

By cGxPwire Editor
June 22, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Frontotemporal Disorders

CervoMed Secures $10 Million to Advance Brain Disease Pipeline